These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes. Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216 [TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse. Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469 [TBL] [Abstract][Full Text] [Related]
14. NO-induced vasodilation correlates directly with BP in smooth muscle-Na/Ca exchanger-1-engineered mice: elevated BP does not attenuate endothelial function. Wang Y; Zhang J; Wier WG; Chen L; Blaustein MP Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H221-H237. PubMed ID: 33124883 [TBL] [Abstract][Full Text] [Related]
15. Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells. Guo Y; Xu C; Man AWC; Bai B; Luo C; Huang Y; Xu A; Vanhoutte PM; Wang Y Cardiovasc Res; 2019 Mar; 115(3):678-690. PubMed ID: 30165439 [TBL] [Abstract][Full Text] [Related]
16. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease. Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice. Thoonen R; Cauwels A; Decaluwe K; Geschka S; Tainsh RE; Delanghe J; Hochepied T; De Cauwer L; Rogge E; Voet S; Sips P; Karas RH; Bloch KD; Vuylsteke M; Stasch JP; Van de Voorde J; Buys ES; Brouckaert P Nat Commun; 2015 Oct; 6():8482. PubMed ID: 26442659 [TBL] [Abstract][Full Text] [Related]